Skip to main content
SpringerLink
Log in

Prognostic Factors for Sporadic Medullary Thyroid Carcinoma

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Introduction

Medullary thyroid carcinoma (MTC) originates from the thyroid parafollicular cells and accounts for 3% to 10% of all thyroid malignancies. Approximately 84% of cases are sporadic. The aim of this study was to evaluate the outcomes of treatment for sporadic medullary thyroid carcinoma (SMTC) and define the prognostic factors for overall survival.

Methods

The records of 32 SMTC patients treated at Ankara Oncology Education and Research Hospital between September 1993 and April 2003 were retrospectively evaluated. The effects of age, gender, tumor localization, extent of the primary surgical resection, tumor size, capsule invasion, lymph node metastasis, extranodal extension, tumor stage, local recurrence, and distant metastasis on the overall survival rate were evaluated by univariate and multivariate analyses.

Results

There were 32 patients (19 females, 13 males) with a median age of 45 years (21–76 years). Altogether, 22 patients had undergone complete resection and 10 patients incomplete resection. The median follow-up was 48 months (9–111 months), and the overall 5-year survival rate was 51%. Based on the univariate analysis, the extent of primary surgical resection, pathologic tumor size, capsule invasion, lymph node invasion, extranodal extension, tumor stage, local recurrence, and distant metastasis were factors that significantly affected survival. In the multivariate analysis, however, only the extent of the primary surgical resection, capsule invasion, and distant metastasis were found to be statistically significant factors.

Conclusions

The extent of the primary surgical resection significantly influences the survival of patients with SMTC. Capsule invasion and distant metastasis were additional factors affecting the prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Clayman GL, el-Baradie TS. Medullary thyroid cancer. Otolaryngol Clin North Am 2003;36:91–105

    Article  PubMed  Google Scholar 

  2. Gilliland FD, Hunt WC, Morris DM, et al. Prognostic factors for thyroid carcinoma: a population-based study of 15,698 cases from the Surveillance Epidemiology and End Results (SEER) program 1973–1991. Cancer 1997;79:564–573

    Article  PubMed  CAS  Google Scholar 

  3. Hundahl SA, Fleming ID, Fremgen AM, et al. A National Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995. Cancer 1998; 83:2638–2648

    Article  PubMed  CAS  Google Scholar 

  4. Alsanea O, Clark OH. Familial thyroid cancer. Curr Opin Oncol 2001;13:44–51

    Article  PubMed  CAS  Google Scholar 

  5. Block MA, Jackson CE, Greenwald KA, et al. Clinical characteristics distinguishing hereditary from sporadic medullary thyroid carcinoma: treatment implications. Arch Surg 1980;115:142–148

    PubMed  CAS  Google Scholar 

  6. Duh QY, Sancho JJ, Greenspan FS, et al. Medullary thyroid carcinoma: the need for early diagnosis and total thyroidectomy. Arch Surg 1989;124:1206–1210

    PubMed  CAS  Google Scholar 

  7. Donis Keller H, Dou S, Chi D, et al. Mutations of the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 1993;2:851–856

    PubMed  CAS  Google Scholar 

  8. Mulligan LM, Kwok JBJ, Healey CS, et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993;363:458–460

    Article  PubMed  CAS  Google Scholar 

  9. Deftos LJ. Medullary Thyroid Carcinoma, Basel, Karger, 1983

  10. Saad MF, Ordonez NG, Rashid RK, et al. Medullary carcinoma of the thyroid: a study of the clinical features and prognostic factors in 161 patients. Medicine 1984;63:319–342

    PubMed  CAS  Google Scholar 

  11. Fife KM, Bower M, Harmer CL. Medullary thyroid cancer: the role of radiotherapy in local control. Eur J Surg Oncol 1996;22:588–591

    Article  PubMed  CAS  Google Scholar 

  12. Treseler PA, Clark OH. Prognostic factors in thyroid carcinoma. Surg Oncol Clin North Am 1997;6:555–598

    CAS  Google Scholar 

  13. Hyer SL, Vini L, A’Hern R, et al. Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival. Eur J Surg Oncol 2000;26:686–690

    Article  PubMed  CAS  Google Scholar 

  14. Modigliani E, Cohen R, Campos JM, et al. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients; the GETC Study Group; Groupe d’Etude des Tumeurs a Calcitonine. Clin Endocrinol (Oxf) 1998;48:265–273

    Article  CAS  Google Scholar 

  15. Bergholm U, Bergstrom R, Ekbom A. Long-term follow-up of patients with medullary carcinoma of the thyroid. Cancer 1997;79:132–138

    Article  PubMed  CAS  Google Scholar 

  16. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual, 6th edition, New York, Springer-Verlag, 2002;77–79

    Google Scholar 

  17. Scopsi L, Sampietro G, Boracchi P, et al. Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. Cancer 1996;78:2173–2183

    Article  PubMed  CAS  Google Scholar 

  18. Raue F. Epidemiology of medullary thyroid carcinoma. Recent Results Cancer Res 1992;125:47–54

    PubMed  CAS  Google Scholar 

  19. Bergholm U, Adami H-O, Auer G, et al. Histopathologic characteristics and nuclear DNA content as prognostic factors in medullary thyroid carcinoma: a nationwide study in Sweden. Cancer 1989;64:135–142

    PubMed  CAS  Google Scholar 

  20. Brierley J, Tsang R, Simpson WJ, et al. Medullary thyroid cancer: analysis of survival and prognostic factors and the role of radiation therapy in local control. Thyroid 1996;6:305–310

    PubMed  CAS  Google Scholar 

  21. Gharib H, McConahey WM, Tiegs RD, et al. Medullary thyroid carcinoma: clinicopathologic features and long term follow-up of 65 patients treated during 1946–1970. Mayo Clin Proc 1992;67:934–940

    PubMed  CAS  Google Scholar 

  22. Kakudo K, Carney JA, Sizemore GW. Medullary carcinoma of the thyroid: biologic behavior of the sporadic and familial neoplasm. Cancer 1985;55:2818–2821

    PubMed  CAS  Google Scholar 

  23. Redding AH, Levine SN, Fowler MR. Normal preoperative calcitonin levels do not always exclude medullary thyroid carcinoma in patients with large palpable thyroid masses. Thyroid 2000;10:919–922

    Article  PubMed  CAS  Google Scholar 

  24. Schmid KW, Ensinger C. “Atypical” medullary thyroid carcinoma with little or no calcitonin expression. Virchows Arch 1998;433:209–215

    Article  PubMed  CAS  Google Scholar 

  25. Belfiore A, La Rosa GL. Fine needle aspiration biopsy of the thyroid. Endocrinol Metab Clin North Am 2001;30:361–400

    Article  PubMed  CAS  Google Scholar 

  26. Boyd LA, Earnhardt RC, Dunn JT, et al. Preoperative evaluation and predictive value of fine needle aspiration and frozen section of thyroid nodules. J Am Coll Surg 1998;187:494–502

    Article  PubMed  CAS  Google Scholar 

  27. Schmidt T, Riggs MW, Speights VO. Significance of non-diagnostic fine needle aspiration of the thyroid. South Med J 1997;90:1183–1186

    PubMed  CAS  Google Scholar 

  28. Haber RS. Role of ultrasonography in the diagnosis and management of thyroid cancer. Endocr Pract 2000;6:396–400

    PubMed  CAS  Google Scholar 

  29. Lin JD, Huang BY, Weng HF, et al. Thyroid ultrasonography with fine needle aspiration cytology for the diagnosis of thyroid cancer. J Clin Ultrasound 1997;25:111–118

    PubMed  CAS  Google Scholar 

  30. Voutilainen PE, Multanen M, Haapiainen RK, et al. Long term prognosis of medullary thyroid carcinoma in 39 patients. Ann Chir Gynaecol 2000;89:292–297

    PubMed  CAS  Google Scholar 

  31. Raue F, Kotzerke J, Reinwein D, et al. Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register. Clin Invest 1993;71:7–12

    Article  CAS  Google Scholar 

  32. Hay ID, Ryan JJ, Grant CS, et al. Prognostic significance of nondiploid DNA determined by flow cytometry in sporadic and familial medullary thyroid carcinoma. Surgery 1990;108:872–880

    Google Scholar 

  33. Rougier P, Parmentier C, Laolanche A, et al. Medullary thyroid carcinoma: prognostic factors and treatment. Int J Radiat Oncol Biol Phys 1983;9:161–168

    PubMed  CAS  Google Scholar 

  34. Bergholm U, Adami HO, Bergstrom R, et al. Long-term survival in sporadic and familial medullary thyroid carcinoma with special reference to clinical characteristics as prognostic factors. Acta Chir Scand 1990;156:37–46

    PubMed  CAS  Google Scholar 

  35. Tennvall J, Bjorklund A, Moller T, et al. Prognostic factors of papillary, follicular and medullary carcinomas of the thyroid gland: retrospective multivariate analysis of 216 patients with a median follow-up of 11 years. Acta Radiol Oncol 1985;24:17–24

    PubMed  CAS  Google Scholar 

  36. Galera-Davidson H, Gonzalez-Campora R, Mora-Marin JA, et al. Cytophotometric DNA measurements in medullary thyroid carcinoma. Cancer 1990;65:2255–2260

    PubMed  CAS  Google Scholar 

  37. El-Naggar AK, Ordonez NG, McLemore D, et al. Clinicopathologic and flow cytometric DNA study of medullary thyroid carcinoma. Surgery 1990;108:981–985

    PubMed  CAS  Google Scholar 

  38. Russell CF, Van Heerden JA, Sizemore GW. The surgical management of medullary thyroid carcinoma. Ann Surg 1983;106:42–44

    Google Scholar 

  39. Samaan NA, Schultz PN, Hickey RC. Medullary thyroid carcinoma: prognosis of familial versus sporadic disease and the role of radiotherapy. J Clin Endocrinol Metab 1988;67:801–805

    Article  PubMed  CAS  Google Scholar 

  40. Palmer BV, Halmer CL, Shaw HJ. Calcitonin and carcinoembryonic antigen in the follow-up of patients with medullary carcinoma of the thyroid. Br J Surg 1984;71:101–104

    PubMed  CAS  Google Scholar 

  41. Simpson WJ, Palmer JA, Rosen IB, et al. Management of medullary carcinoma of the thyroid. Am J Surg 1982;144:420–422

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Ankara Oncology Education and Research Hospital, Demetevler, Ankara, TR-06200, Turkey

    Kaptan Gülben MD, Uğur Berberoğlu MD & Mustafa Boyabatlı MD

  2. Kaptan Gülben, Urankent Sitesi, C-9 Blok, No. 33, Demetevler, Ankara, TR-06200, Turkey

    Kaptan Gülben MD

Authors
  1. Kaptan Gülben MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Uğur Berberoğlu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mustafa Boyabatlı MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kaptan Gülben MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gülben, K., Berberoğlu, U. & Boyabatlı, M. Prognostic Factors for Sporadic Medullary Thyroid Carcinoma. World J. Surg. 30, 84–90 (2006). https://doi.org/10.1007/s00268-005-7949-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-005-7949-z

Keywords

Search

Navigation